Online Referral and Intervention to Prevent Adolescent and Young Adult Suicide

Recruiting now · Not applicable

Conditions studied: Suicide

In brief

ORIAS is a randomized controlled trial designed to study the efficacy of the ELIOS system in reducing suicidality in the AYA, reinforcing their motivation to seek help and making them access to care. As ELIOS would be the first suicide prevention system worldwide entirely tailored to the AYA contemporaneous modes of interaction on social media, ORIAS was designed to address the challenge of deciding whether this innovation is worth adding to the current national and international prevention arsenal. While randomized control trials are crucially lacking in the field of suicide prevention, especially on the Internet, the high-level evidence that ORIAS is expected to bring could have a decisive influence on how the French prevention strategies will seize the social media.

Key facts

Study ID

NCT04642157

Run by

University Hospital, Lille

People needed

396

Starts

2022-10-13

Expected to finish

2026-07-13

Last updated by the study team

2025-06-27

Who can join

Age: 18 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• To spontaneously contact the ELIOS online system
• To have been experiencing suicidal ideations in the week prior the contact
• To live in France and speak French
• To provide informed consent
• For ethical reasons, we decided not to include minors, due to impossibility of getting the parental authorizations without compromising the facilitation role of the system. However, most recent expert consensus consider that adolescence extends to 25 years old.

You may not qualify if…

• To contact the ELIOS online system for a relative or an acquaintance

Where it is running

• CHU de Lille — Lille, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.